(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | $153.41 | $162.74 | $175.53 | $209.15 |
Short term investments | ||||
Net receivables | $51.21 | $47.99 | $47.36 | $44.18 |
Inventory | ||||
Total current assets | $223.91 | $225.47 | $239.03 | $267.41 |
Long term investments | ||||
Property, plant & equipment | $493.26 | $482.86 | $468.93 | $456.95 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $791.69 | $785.33 | $787.54 | $806.61 |
Current liabilities | ||||
Accounts payable | $12.58 | $16.16 | $10.09 | $10.13 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $102.27 | $90.09 | $81.63 | $89.35 |
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $1136.51 | $771.73 | $761.87 | $967.2 |
Shareholders' equity | ||||
Retained earnings | -$344.86 | -$77.49 | -$67.11 | -$248.55 |
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $209.15 | $246.19 | $484.88 | $0.99 |
Short term investments | ||||
Net receivables | $44.18 | $19.09 | $12.18 | $5.42 |
Inventory | ||||
Total current assets | $267.41 | $275.48 | $506.35 | $1.25 |
Long term investments | ||||
Property, plant & equipment | $456.95 | $359.97 | $133.28 | $71.27 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $230 | |||
Total investments | ||||
Total assets | $806.61 | $729.72 | $746.32 | $231.26 |
Current liabilities | ||||
Accounts payable | $10.13 | $9.13 | $2.95 | $3 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $89.35 | $87.34 | $46.87 | $0.75 |
Long term debt | ||||
Total noncurrent liabilities | $225.51 | |||
Total debt | ||||
Total liabilities | $967.2 | $1087.82 | $2104.65 | $226.26 |
Shareholders' equity | ||||
Retained earnings | -$248.55 | -$375.66 | -$1358.36 | -$14.3 |
Other shareholder equity | $184.61 | |||
Total shareholder equity |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $67.53 | $66.62 | $55.16 | $49.99 |
Cost of revenue | ||||
Gross Profit | $6.37 | $6.4 | $6.84 | $3.54 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $37.42 | $35.96 | $34.32 | $40.93 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $0.03 | $0.06 | $0.01 | |
Interest expense | $1.81 | $2.06 | $2.27 | $2.65 |
Net income | ||||
Net income | -$11.63 | -$10.31 | -$9.77 | -$12.27 |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $160.95 | $54.59 | $22.21 | |
Cost of revenue | ||||
Gross Profit | $9.71 | -$5.65 | -$6.83 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $151.63 | $143.85 | $83.01 | $1.01 |
Operating income | -$1.01 | |||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $0.04 | $0.02 | ||
Interest expense | $9.74 | $3.64 | -$1.25 | |
Net income | ||||
Net income | -$42.09 | -$27.29 | -$5.91 | -$14.3 |
Income (for common shares) |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$70.87 | -$45.12 | -$21.02 | -$143.31 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $9.55 | $5.23 | $1.49 | $143.02 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$55.74 | -$46.41 | -$33.62 | -$37.35 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Net income | -$14.3 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$0.55 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$143.31 | -$199.71 | -$87.77 | -$230 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $143.02 | $19.81 | $594.63 | $231.54 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$37.35 | -$238.69 | $477.26 | $0.99 |
Market cap | $309.29M |
---|---|
Enterprise value | N/A |
Shares outstanding | 106.28M |
Revenue | $239.31M |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | -$43.97M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | -7.03 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 1.29 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | 1.44 |
EPS | -$0.41 |
---|---|
ROA | -5.55% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 2.19 |
Quick ratio | N/A |